Chemotherapy Following PD-1 Inhibitor Blockade in Patients with Unresectable Stage III/Stage IV Metastatic Melanoma: A Single Academic Institution Experience
Sign Up to like & getrecommendations! Published in 2019 at "Oncology"
DOI: 10.1159/000504578
Abstract: Retrospective case studies in various cancers have shown clinical benefit from chemotherapy following PD-1 inhibitor progression. We asked whether we see a similar clinical benefit with chemotherapy following PD-1 inhibitor progression in metastatic melanoma. We… read more here.
Keywords: chemotherapy; inhibitor; chemotherapy following; following inhibitor ... See more keywords
Salvage Chemotherapy Following Osimertinib in Non-small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutation
Sign Up to like & getrecommendations! Published in 2020 at "AntiCancer Research"
DOI: 10.21873/anticanres.14186
Abstract: Aim: The current study reports the type of salvage chemotherapy following osimertinib and its treatment efficacy in patients with non-small-cell lung carcinoma (NSCLC) who acquire resistance to osimertinib. Patients and Methods: In this retrospective cohort… read more here.
Keywords: following osimertinib; chemotherapy following; salvage chemotherapy;